ClinicalTrials.gg
Sign In

Skin Diseases, Infectious clinical trials

The registry lists 45 studies for Skin Diseases, Infectious across more than 10 countries. 2 are recruiting or about to start. 16 of them are mainly about Skin Diseases, Infectious (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-20. Counting its 21 narrower conditions too, such as Hidradenitis Suppurativa: 1,662 studies, 241 open.

Get an email when these change. Save the Skin Diseases, Infectious studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
35
Terminated
4
Not yet recruiting
2
Status unknown
2
Active, not recruiting
1
Withdrawn
1

Phase

Phase 2
12
Phase 3
12
Phase 4
8
Phase 1
2

Where

United States
18
Taiwan
2
Argentina
2
Japan
2
Mexico
2
Canada
2

Who runs them

Wyeth is now a wholly owned subsidiary of Pfizer (3) · Basilea Pharmaceutica (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Shenzhen Shenxin Biotechnology Co., Ltd (2) · Pfizer (2) · Merck Sharp & Dohme LLC (2) · Drugs for Neglected Diseases (2) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2)

What is being tested here

Drugs under test in Skin Diseases, Infectious studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Naproxen111
Daptomycin013
Tedizolid phosphate023
Tedizolid023
Tigecycline013
Emodepside002
Omadacycline012
Ceftobiprole medocaril022
Levofloxacin022
VP-102001

Coming up

1phase 3 study under way
0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

No Skin Diseases, Infectious study is recruiting now.

Across all 45 studies, recruiting or not: 33% stop at 75 or younger and 27% at 65; 33% take children; 2% are for women only and 4% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 45 of 45. search them.